Clinical Trial

The UFO (Ultra Processed Foods in Obesity) Project

Study acronym: UFO Project
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The childhood obesity prevalence has increased dramatically in the last decades, affecting more than 340 million children worldwide. This condition is the major risk factor for a set of metabolic abnormalities, also known as metabolic syndrome, a condition that reduce life expectancy by 5-20 years. Changes in the global food system, and the increased consumption of ultra-processed foods (UPFs), may have contributed to the increase in the prevalence of childhood obesity and related morbidities. The mechanisms by which UPFs might promote obesity and metabolic syndrome could be multiple and not completely identified. The Ultra-processed Food in Obesity (UFO) Project has been designed to investigate the potential associations between UPFs intake and MetS in pediatric subjects
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-09-21; most recent amendment 2025-06-03.
Trial Details
NCT Number NCT05554016
Lead Sponsor Federico II University
Conditions Obesity, Morbid, Metabolic Syndrome
Enrollment 200 participants
Start Date 2022-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-04